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Abstract
Background: This study was conducted to investigate the protective effect of Tongmai oral liquid on arteriovenous
fistula function and to provide an effective method to promote fistula maturation.
Methods: Fifteen female and fifteen male SPF New Zealand rabbits were randomly allocated into 3 groups
including control, Aspirin and Tongmai oral liquid groups. A side-to-side femoral arteriovenous fistula was
established in each rabbit and then animals were treated with Aspirin or Tongmai oral liquid for 2 weeks. The
concentrations of circulating ET-1 and NO were determined before and after operation (on preoperative day,
operative day, post-D1, post-D3, post-D7 and post-D15), respectively. Blood flow of the fistula stoma and
contralateral artery and vein was determined on the 15th postoperative day. Last, the fistula stoma was dissected to
observe patency, thrombosis and adhesion with surrounding tissues.
Results: 28 rabbits survived during the surgical process and the following 15-day observational period. Tissue
adhesion of arteriovenous fistula with surrounding tissues was improved and fistula thrombosis was reduced by
treatment with Tongmai oral liquid. NO concentration decreased to a different extent after vascular surgery.
Tongmai oral liquid failed to regulate the equilibrium between NO and ET-1, but it improved blood flow of fistula
stoma, as compared to control and Aspirin groups. Blood flow of fistula stoma in the three groups was lower than
that of the contralateral femoral artery.
Conclusions: Tongmai oral liquid improved the function of femoral ateriovenous fistula in the rabbit model by
increasing blood flow and reducing thrombosis, probably not by regulating the dynamic equilibrium between NO
and ET-1.
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Background
Arteriovenous fistula (AVF) is the first choice for vascu-
lar access in hemodialysis patients with chronic kidney
diseases. However, it is very difficult to create a func-
tional AVF in senile patients and patients with blood
hypertension and diabetes. Moreover, it also costs a lot
to maintain AVF and to reduce vascular access-related
complications [1]. Because of the frequent failure of mat-
uration of a newly created AVF [2], more and more re-
searchers focus on early fistula maturation.
It has been shown that thrombosis and venous sten-
osis as a result of neointimal hyperplasia, reduction of
blood flow and inadequate dilatation of the venous seg-
ment are common causes that contribute to early AVF
dysfunction [3–6]. Endothelin-1 (ET-1) and nitric oxide
(NO) are mutually antagonistic vasoactive substances se-
creted by vascular endothelial cell. The dynamic equilib-
rium of ET-1 and NO is important to maintain normal
vascular angiotasis and hemodynamics, and such a bal-
ance can regulate endothelial cell proliferation and plate-
let aggregation [7, 8]. In addition to modulating the
contractile state and migration of Vascular Smooth
Muscle Cells (VSMC), NO can also inhibits VSMC pro-
liferation [9]. However, the AVF surgery brings injury to
endothelial cells and breaks the balance between ET-1
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and NO. Besides, chronic kidney disease itself increases
neointimal formation and endothelial barrier dysfunction
[10]. However, there are no effective methods to improve
the early fitula maturation or protect the ateriovenous
fistula function so far.
Tongmai oral liquid has been used to treat chronic
kidney disease since 1995 in clinical practice of Chinese
medicine. It is consisted of radix astragali and radix
notoginseng, which are selected based on traditional
Chinese medical theory and modern pharmacological
studies of Chinese herbal medicine. The main effective
ingredients of Tongmai oral liquid are total saponins
and total polysaccharides, which can reduce plasma vis-
cosity as well as erythrocyte aggregation index [11]. Our
clinical observations showed that it can improve uncom-
fortable symptoms of patients with glomerulonephritis,
such as edema, fatigue, bad appetite, soreness and weak-
ness of waist and knees. And laboratory examinations of
the levels of serum creatinine, blood urea nitrogen, 24-h
protein excretion, total cholesterol, triglyeride, fibrin
degradation product and fibrinogen also decreased to a
different extent by treatment with Tongmai oral liquid
[12]. Importantly, previous studies showed that Tongmai
oral liquid can inhibit platelets’ activation, improve renal
hemodynamics, ameliorate hemodialysis patients’ micro-
inflammatory state, and improve blood high condensa-
tion state [13–16], etc. Therefore, in the present study,
we hypothesized that Tongmai oral liquid may potenti-
ate the vascular endothelial cell function and blood flow
to promote fistula maturation.
Methods
Consent
Approval was obtained from Animal Experimental Ethics
Committee of Guangzhou University of Chinese Medicine
prior to performing any procedures on animals.
Experimental animals
The study was carried out in the Laboratory Animal
Centre of Guangzhou University of Chinese Medicine.
Fifteen female and fifteen male specified-pathogens free
(SPF) New Zealand rabbits weighing 2.2-2.4 kg were
used (Huadu experimental animal farm, Guangzhou,
China, certificate number: 1084322). They were kept in
a climate-controlled room with 25 °C and 37 % relative
humidity. These rabbits were randomly allocated into 3
groups (control, Aspirin, and Tongmai oral liquid group)
according to a random table. Each group consisted of 10
rabbits.
Drugs
Tongmai oral liquid with bath number of 110303 (con-
sisted of Astragalus Membranaceus 3 g and Notoginseng
Radix 1 g per 10 ml) were prepared and provided by the
Department of Pharmacology in Guangdong Provincial
Hospital of Chinese Medicine, Guangzhou, China. Aspirin
(bath number BJ02005, Bayer Healthcare Co. Ltd) was
also provided by the Department of Pharmacology in
Guangdong Provincial Hospital of Chinese Medicine,
Guangzhou, China.
Administration method and dosage
Administration dosage was determined according to
dose convert coefficient table which is applicable to hu-
man and animal dose conversion. The convert coeffi-
cient W is 2.3 and the formula is Db (mg/kg) =W×Da
(mg/kg) [17]. Namely, the administration dose of B ani-
mal is equal to W multiplied by that of A animal.
Human’s dosage of Tongmai oral liquid is 60 ml per day,
and Aspirin dosage is 100 mg per day.
According to this dosage conversion, solution of As-
pirin was made with concentration of 0.77 mg/ml and
was administered to rabbits in Aspirin group by 5 ml/kg.
The control group was given normal saline (5 ml/kg).
The experimental group was given Tongmai oral liquid
(5 ml/kg). These drugs were all given by intragastric ad-
ministration on the day after AVF operation for 14 days.
Establishment of femoral arteriovenous fistula
After randomly allocated, rabbits were anesthetized with
pentobarbital sodium (3 % volume fraction, 1 ml/kg) via
ear vein injection. Subsequently, they were fixed in a su-
pine position with left leg extended, shaved and sterilely
prepared. Through a skin incision 2 cm under the left
groin ligament, femoral artery and femoral vein were
dissected and exposed. All branches of the femoral ar-
tery and vein were ligated. The two vessels were both
clamped proximally and distally. A 5–6 mm long inci-
sion was made on adjoining sides of the artery and vein
respectively and heparin saline (100 IU/ml) was used to
syringe the wounds. Then the wounds were saturated
with 12–0 atraumatic suture to form a side-to-side fem-
oral artery to vein anastomosis. Next, the vascular
clamps were loosed and anastomotic vessels were patent.
Finally, the skin was closed with interrupted suture using
4–0 suture and covered with erythromycin ophthalmic
ointment to prevent infection.
Determinations of circulating ET-1 and NO concentration
Blood samples (2 ml) were collected from central aur-
icular artery in each group on preoperative day, opera-
tive day, post-D1, post-D3, post-D7 and post-D15. ET-
1 concentration was determined by using 96 T rabbit
ET-1 enzyme linked immunosorbent assay (ELISA) kit
(American R&D systems, Batch No.CSB-E06951Rb)
[18]. NO concentration was determined by using 96 T
rabbit NO ELISA kit (American R&D systems, Batch
No.KGE001) [18].
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Measurement of blood flow
Blood flow of fistula stoma was determined by using an
ultrasonic flow probe (Transonic System, Ithaca, NY) on
the 15th postoperative day, following exposure of anasto-
motic vessels. Blood flow was recorded every 5 s, and
the totally observational time was 1 min. Meanwhile,
this procedure was also used to test blood flow of the
contralateral femoral artery and vein at the same pos-
ition. The fistula stoma was next dissected to observe
patency, thrombosis and adhesion with surrounding tis-
sues. Finally, the animals were executed by euthanasia.
Statistical analysis
Data are reported as mean ± SD. Data were analyzed by
one-way ANOVA or repeated measures analysis of vari-
ance. P-values of <0.05 were regarded as significant. All
calculations were made with SPSS 17.0 software.
Results
Surgical procedure
Two rabbits in the control group died during the surgi-
cal procedure. One died of overdose of anesthesia. The
other was executed because it regained consciousness
during the operation process and was struggled strongly
to break the operative vessels. Finally, AVFs were suc-
cessfully established in 28 rabbits, with 8 in control
group, 10 in Aspirin group, and another 10 in Tongmai
group. All the 28 rabbits survived during the15-day ob-
servational period.
Fistula observations
As shown in Table 1, in Tongmai group, there was one
small thrombosis in one fistula stoma with decreased
blood flow, while in the other two groups two stomas
were completely blocked by thrombosis, with no blood
flow. Compared with Aspirin and control groups, tissue
adhesion in Tongmai group was significantly reduced by
30 and 60 % respectively. These observations indicated
that Tongmai oral liquid could prevent thrombosis and
reduce tissue adhesion of AVF with surrounding tissues.
NO and ET-1 concentration measurements
The concentrations of NO and ET-1 were determined
before and after operation, as shown in Tables 2 and 3.
NO concentrations were significantly different at the
indicated time points after surgery (F = 19.267, P =
0.000), both in Aspirin group (F = 1.167, P = 0.005) and
Tongmai group (F = 59.258, P = 0.002), except that in
control group (F = 1.207, P = 0.326). During the observa-
tional period, NO concentration was decreased to a dif-
ferent extent in each group following vascular surgery,
which was in accordance with previous literatures [19].
The change of NO concentration was of no significance
among three groups (F = 0.817, P = 0.453). Interaction ef-
fect existed between different treatment methods and
time points (F = 4.299, P = 0.002). After a transient de-
cline (lowest on post-D1), NO concentration increased
gradually during the following observational days, as il-
lustrated in Fig. 1.
ET-1 levels were significantly different after surgery
(F = 2.669, P = 0.025), especially in control group (F =
4.298, P = 0.004), while of no significance in both As-
pirin group (F = 1.690, P = 0.156) and Tongmai group
(F = 0.659, P = 0.656). The change of ET-1 concentra-
tion was not significant among the three groups (F =
3.179, P = 0.059). Interaction effect existed between
different treatment methods and time points (F =
2.274, P = 0.018). After surgery, ET-1 levels in Tongmai
and control groups increased to a peak on post-D1 and
post-D7 respectively, and subsequently decreased in
both groups, as demonstrated in Fig. 2.
Blood flow measurements
Blood flow of fistula stoma, contralateral femoral artery
and vein was measured on the 15th postoperative day.
Fistula blood flow was significantly lower than that of the
contralateral femoral artery in the same group (P < 0.05).
And this outcome was mildly improved by Tongmai oral
liquid although there was no significance among three
groups (F = 1.668, P = 0.209). On the other hand, blood
flow of the contralateral femoral artery was at similar level
among three groups (P > 0.05), indicating that Aspirin and
Tongmai oral liquid did not play a role in the healthy ves-
sel (Table 4).
Discussion
Thrombosis and venous stenosis as a result of neointi-
mal hyperplasia are leading causes for AVFs dysfunction
[3, 4]. Mechanisms of neointimal hyperplasia are related
to endothelial cell damage, inflammation, decrease of
NO synthesis, migration of myofibroblasts, oxidative
stress and laminar fluid shear stress [20]. In addition,
upregulation of transforming growth factor beta1 (TGF-
beta1) plays an important role in the process of neointi-
mal hyperplasia by promoting fibroblasts proliferation
[21, 22] and stimulating adventitial fibroblasts trans-
forming to myofibroblasts and migration [23]. Besides,
surgical trauma to the vasa vasorum of the outflow vein
can promote adventitial myofibroblasts migration as well
Table 1 Fistula observations in each group on the 15th
postoperative day
Number Fistula observations
Groups (n) Tissue adhesion Thrombosis
Control group 8 8 2
Aspirin group 10 7 2
Tongmai group 10 4 1
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as lead to neointimal hyperplasia [24]. Of note, our pre-
vious studies showed that Tongmai oral liquid can sup-
press production of TGF-beta1 in diabetic nephropathy
murine models and mesangial proliferative glomerulo-
nephritis rats [25, 26]. Therefore, we hypothesized that
Tongmai oral liquid is applied for improving AVFs
dysfunction.
In traditional Chinese medical theory, the complex
process of neointimal hyperplasia and stenosis is, at least
in part, due to Qi-deficiency and the subsequent blood
stasis. Qi-deficiency and blood stasis exists in the pro-
gression of chronic kidney disease [27], and the surgical
procedure of establishing an arteriovenous fistula aggra-
vates injuries of blood vessels and Qi activities. Modern
studies of Chinese medicine consider blood stasis as
blood circulation obstacle, such as thrombosis and plate-
let aggregation [28], which is closely related to endothe-
lial cell injury, high blood viscosity and inflammatory
response [29–31]. Tongmai oral liquid was made from
several Chinese herbals (Table 5) which can relieve
blood stasis via nourishing Qi. For example, the pharma-
cological studies have shown that both astragali and
radix notoginseng can improve hemorrheology, anti-
platelet aggregation, and promote fibrinolysis to reduce
thrombosis [32–35]. Moreover, we previously reported
that Tongmai oral liquid is able to ameliorate
hemodialysis patients’ micro-inflammatory state and in-
hibit platelets’ activation [13, 15]. Furthermore, as shown
in Table 4, Tongmai oral liquid could increase blood
flow of fistula stoma, compared with Aspirin and control
group (8.80 ± 4.24 vs 6.00 ± 3.49 vs 6.00 ± 3.89 ml/min).
In rabbit AVF model, 2 weeks’ treatment of Tongmai
oral liquid could improve tissue adhesion around the
AVF and reduce thrombosis. As shown in Table 1, tissue
adhesion in Tongmai group was significantly reduced by
30 and 60 % respectively compared with Aspirin and
control groups. Aspirin treatment served as positive
control, since it is an effective antiplatelet aggregation
drug to prevent fistula thrombosis [36] and improve
AVF survival [37]. Aspirin’s effect of anti-thrombosis
Table 2 Changes of NO concentration (umol/L, x ± S)
Group N Before or After operation F P
Preoperat-ive day Operative day Post-D1 Post-D3 Post-D7 Post-D15
Control group 8 x 271.31 243.97 251.34 216.21 250.84 225.90 1.207 0.326
s 18.17 14.49 56.81 55.82 63.18 79.20
Aspirin group 10 x 275.85 274.34 163.44 187.58 218.32 269.46 1.167 0.005
s 14.39 10.78 20.65 27.74 14.23 24.45
Tongmai group 10 x 272.57 282.24 178.70 205.55 240.90 232.32 59.258 0.000
s 22.12 17.95 32.11 23.35 28.67 84.64
Sum 28 x 273.38 268.49 194.00 202.18 235.67 243.75 19.267* 0.000*
s 17.93 21.79 52.24 37.25 39.58 67.83
F 0.817* 0.148 16.269 13.297 1.419 1.724 0.150 (F = 4.299 P = 0.002) **
P 0.453* 0.863 0.000 0.000 0.261 0.199 0.333
* F statistic and P value of main effect; b F statistic and P value of interaction effect
Table 3 Changes of ET-1 concentration (pg/ml, x ± S)
Group n Before or After operation F P
Preopera-tive day Operative day Post-D1 Post-D3 Post-D7 Post-D15
Control group 8 x 7.66 7.50 7.57 7.75 8.42 7.78 4.298 0.004
s 0.54 0.47 0.53 0.60 0.58 0.59
Aspirin group 10 x 7.59 7.30 7.44 7.55 7.44 7.37 1.690 0.156
s 0.57 0.34 0.35 0.54 0.44 0.49
Tongmai group 10 x 7.50 7.63 8.01 7.81 7.76 7.59 0.659 0.656
s 0.50 0.45 0.56 0.34 0.59 0.55
Sum 28 x 7.58 7.47 7.68 7.70 7.84 7.57 2.669* 0.025*
s 0.52 0.43 0.53 0.49 0.65 0.55
F 3.179* 0.217 1.541 3.796 0.746 7.500 1.342 (F = 2.274 P = 0.018)**
P 0.059* 0.806 0.234 0.036 0.485 0.003 0.280
* F statistic and P value of main effect; ** F statistic and P value of interaction effect
Su et al. BMC Complementary and Alternative Medicine  (2015) 15:311 Page 4 of 7
seemed not to be effective enough in this model, which
could be due to reduction of blood flow. Altogether, our
results strongly suggest that Tongmai oral liquid can
promote a well functional AVF through, at least in part,
increasing blood flow as well as suppressing neointimal
hyperplasia.
It is well known that ET-1 is a powerful vasocon-
strictor while NO is a potent vasodilative substance [7].
The impairment of the balance between NO and ET-1
can induce endothelial cell dysfunction [8]. To determine
if Tongmai oral liquid could promote blood circulation by
improving endothelial cell function, concentrations of NO
Fig. 1 Change of NO concentrations during the observational period
Fig. 2 Change of ET-1 concentrations during the observational period
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and ET-1 were evaluated in our model studied. Unfortu-
nately, the data showed that Tongmai oral liquid and As-
pirin only slightly reversed the downward trend of NO
after operation, which was of no statistical significance.
Interestingly, in our rabbit AVF models, blood flow of
fistula stoma was generally low in each group, even
lower than that of the contralateral femoral artery which
is contrary to clinical practice and other animal AVF
models [38–43]. Though reduction of fistula blood flow
is frequently in the period of fistula maturation and
maintains, both clinical and experimental studies dem-
onstrated increased blood flow of fistula and cardiac out-
put as well as decreased systematic vascular resistance
following the creation of AVF. Since it is a newly created
AVF with successful surgical procedure, the following
aspects are possibly to be considered for contributing to
low blood flow: 1) Surgery itself is an injurious strike to
normal blood vessel anatomy to cause pathological
changes of blood milieu internae and hemodynamics. 2)
Stenosis of fistula stoma and out-flow vein tract caused
by neointimal hyperplasia and vascular remodeling. A
previous study in a rodent femoral artery to vein fistula
[44] demonstrated apparently polypoid neointimal
hyperplasia at the anastomosis venous lesion on the 14th
day after surgery. 3) Underlying thrombosis. 4) The ob-
servational period was too short for a fistula to maturate.
Therefore, it is worth doing the further studies in our
model established to clarify all the questions raised, es-
pecially to detect the role of Tongmai oral liquid in ven-
ous stenosis.
There are also some limitations in our study. Since
Tongmai oral liquid has special colour and taste which
can be distinguished from other drugs easily by the ex-
perimenter, double blind method is difficult to imple-
ment during the experimental process. Besides, though
sample size of the study was determined based on
experimental estimation, it still seems not sufficient
enough. We plan to expand sample size and try to over-
come the technical problem of implementing blinding
method in our further study.
Conclusions
In conclusion, Tongmai oral liquid improved the func-
tion of femoral AVF in the rabbit model by increasing
blood flow and reducing thrombosis. The mechanisms
of this protective effect are probably not relevant to
regulating the dynamic equilibrium between NO and
ET-1. Further studies are needed to examine the role of
Tongmai oral Liquid in venous stenosis in rabbit AVF
model.
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